17-ketosteroids and Dermatitis--Seborrheic

17-ketosteroids has been researched along with Dermatitis--Seborrheic* in 5 studies

Reviews

1 review(s) available for 17-ketosteroids and Dermatitis--Seborrheic

ArticleYear
[Clinical aspects of the anti-androgens].
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979, Mar-24, Volume: 55, Issue:13

    The ongoing development and gradual availability of the new anti-androgens hold exciting clinical implications for the future. The biosynthesis and interchangeability of the sex steroids, the roles of the ovaries and adrenals and the value and interpretation of biochemical assays in clinical practice are briefly discussed. Because the anti-androgens are used primarily for seborrhoea/acne/hirsutism/oligomenorrhoea, the pathophysiological basis of this socially debilitating syndrome is discussed. The classification of the anti-androgens, their indications, side-effects, dosage schemes and results of treatment are reviewed. Finally, a summary of a possible clinical management regimen is presented.

    Topics: 17-Ketosteroids; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Androsterone; Contraceptives, Oral, Hormonal; Cyclopentanes; Cyproterone; Dermatitis, Seborrheic; Dihydrotestosterone; Estradiol Congeners; Female; Follicle Stimulating Hormone; Glucocorticoids; Hirsutism; Humans; Hydroxysteroids; Luteinizing Hormone; Male; Medroxyprogesterone; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; Sex Hormone-Binding Globulin; Steroids; Testosterone

1979

Trials

1 trial(s) available for 17-ketosteroids and Dermatitis--Seborrheic

ArticleYear
[The treatment of virilizing syndromes. Comparative clinical studies of 2 antiandrogen-active gestagens (cyproterone acetate, megestrol acetate].
    Die Medizinische Welt, 1975, Nov-28, Volume: 26, Issue:48

    Treatment of virilization symptoms in 230 patients is reported. 68 patients were treated with Planovin (4 mg megestrol acetate and .05 mg ethinyl estradiol), 77 with SH81041 (100 mg Cyproterone acetate for 10 days and .05 mg ethinyl estradiol for 21 days), and 85 were treated first and Planovin and then with SH81041. Acne, seborrhea, hirsutism, and alopecia improved under treatment with each preparation; results were similar with acne and alopecia, while SH81041 was somewhat more effective than Planovin in treating seborrhea and hirsutism. Therapeutic results obtained during treatment with SH81041 in acne and alopecia are retained during Planovin treatment, but seborrhea and hirsutism become worse again. Successful treatment was independent of the severity of hirsutism and the duration of of treatment. Side effects included breakthrough bleeding and sweating.

    Topics: 17-Ketosteroids; Acne Vulgaris; Adolescent; Adult; Alopecia; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Hirsutism; Humans; Megestrol; Virilism

1975

Other Studies

3 other study(ies) available for 17-ketosteroids and Dermatitis--Seborrheic

ArticleYear
Therapy of androgenetic sympatomatology with cyproterone acetate and ethinyl estradiol.
    Archiv fur Gynakologie, 1978, May-12, Volume: 225, Issue:2

    The effectiveness of therapy with cyproterone acetate and ethinyl estradiol was studied in 103 women. Acne and seborrhea responded best with 91.7 and 93.3% respectively, including complete and partial therapeutic success. For hirsutism complete remission and partial improvement were found in 75.3% of the treated women. Under therapy, body weight did not change in 51.9%, while 24.7% of the patients gained weight and 23.4% lost weight. The cycle length remained normal after therapy in 35.8%. Normalization or improvement was found in 54.7%. In 6.3% no improvement was noted after therapy and in 3.2% cycle irregularity developed in women with previous undisturbed pattern. According to BBT, improvement of the functional capacity of the reproductive system was found in 32.9% of the patients. Only 3% of the women studied demonstrated a deterioration. The 17-ketosteroid excretion was diminished in 35.3% after therapy and remained unchanged in 64.7%. The therapeutic regimen used for the study was well tolerated and good cycle control was obtained.

    Topics: 17-Ketosteroids; Acne Vulgaris; Adolescent; Adult; Body Temperature; Body Weight; Cyproterone; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstruation; Menstruation Disturbances; Remission, Spontaneous

1978
[Trial evaluation of the therapeutic value of the ovulation inhibitors in seborrhea and acne vulgaris].
    Bulletin de la Societe francaise de dermatologie et de syphiligraphie, 1968, Volume: 75, Issue:1

    Topics: 17-Ketosteroids; Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral; Dermatitis, Seborrheic; Estrogens; Female; Humans; Hypertrichosis; Menstruation Disturbances; Mestranol; Ovulation; Progestins; Virilism

1968
[On the determination of testosterone and additional alpha, beta-unsaturated ketosteroids of the C19 series in urine].
    Endokrinologie, 1968, Volume: 53, Issue:5

    Topics: 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Alopecia; Androstanes; Breast Diseases; Chemistry, Clinical; Chorionic Gonadotropin; Chromatography, Paper; Dehydroepiandrosterone; Dermatitis, Seborrheic; Female; Follicle Stimulating Hormone; Humans; Klinefelter Syndrome; Male; Middle Aged; Radiation Injuries; Testis; Testosterone

1968